Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.,Critical Reviews in Eukaryotic Gene Expression

当前位置： X-MOL 学术 › Crit. Rev. Eukaryot. Gene Expr. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies.
Critical Reviews in Eukaryotic Gene Expression ( IF 1.5 ) Pub Date : 2021-01-01 , DOI: 10.1615/critreveukaryotgeneexpr.2021038075
Muhammad Hassan ₁ , Muhammad Zalkifal ₂ , Abdul Wahab ₃ , Samia Afzal ₁ , Shazia Rafique ₁ , Muhammad Shahid ₄ , Mohsin Ahmad Khan ₁ , Nadeem Ahmed ₁ , Muhammad Idrees ₅ , Ahmad Ali Shahid ₁

Affiliation

Coronaviruses (CoVs) are continuously emerging, highly transmissible, and pathogenic agents that primarily target the human respiratory system. Previous outbreaks of severe acute respiratory syndrome-CoV and Middle East respiratory syndrome-CoV remain life-threatening and global public health concerns. A novel CoV outbreak that occurred in December 2019 in Wuhan, China was declared a pandemic outbreak that has since killed millions of individuals worldwide. Rapid transmission, genetic variations, and unavailability of specific therapeutic drugs are major factors that led to this alarming and deadly situation. Currently, > 200 clinical vaccine trials are underway to combat infection. This review summarizes reports related to CoV origin, genetic variations, drug options, status of nine vaccines that were in phase III trials, and novel therapies including convalescent plasma and stem cell treatment.

更新日期：2021-01-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11